COPPELL, Texas--(BUSINESS WIRE)--Sep. 29, 2015--
Mannatech,
Incorporated (NASDAQ: MTEX),
the founder of the M5MSM
(Mission 5 MillionSM) Foundation, the pioneer of
glyconutrition and the global innovator of naturally sourced supplements
based on Real
Food Technology® solutions, announced the creation of a
global Scientific Advisory Board. The Scientific Advisory Board will be
comprised of third-party experts in the medical, science, health and
wellness fields to further support and advance Mannatech’s continued
commitment to providing groundbreaking, science-backed nutritional
supplements to its worldwide customer base.
The Mannatech Scientific Advisory Board will begin organizing its
membership of doctors, scientists and wellness experts immediately.
Mannatech’s Global Wellness Director, Dr. Steve Nugent, will chair the
advisory board. Mannatech staff, including Rolando Maddela, M.D., (MPH,
CCRP) Mannatech’s Director of Clinical Research and Scientific Affairs
and Tait Switzer, Vice President of Research and Development, will also
support Dr. Nugent and the board members.
This global Scientific Advisory Board is part of CEO
and President, Al Bala’s vision for ensuring that Mannatech delivers
innovative nutritional technology and products that are supported by
clinical trials and scientific validation. This safeguards that
Mannatech products provide real results and improve the overall wellness
of customers.
“Establishing the Scientific Advisory Board demonstrates Mannatech’s
commitment to providing the highest quality, science-backed technologies
that will delight our customers and that our sales Associates can use
effectively to build their business around the world,” said Bala. “While
there are many skincare and nutritional supplement companies, few have
the technology that Mannatech has, which is backed by clinical studies,
industry leading quality controls and patents. The Scientific Advisory
Board, under the leadership of Dr. Nugent, will bring substantial and
important expertise to our overall technology and product development
process.”
Dr. Nugent brings to the Scientific Advisory Board more than 38 years of
experience in the health and wellness industry. He has tested more than
6,000 dietary supplement products and has formulated more than 100
products. Dr. Nugent earned his doctorate from the University of the
Rockies and is well respected worldwide as an authority on nutritional
technology. He has been a source of knowledge and inspiration for
Mannatech Associates who rely on his insights to help build strong and
safe long-term businesses.
“It is a great honor for me to be asked to lead an independent board of
experts to help continue Mannatech’s tradition of producing products
validated by science,” said Dr. Nugent. “The Board’s mission is to
provide objective, expert leadership to Mannatech and to ensure its
technologies meet the highest standards. Mannatech’s foundation is built
on science, and this board will ensure the company receives the most
current feedback from scientists and wellness leaders from around the
world.”
Mannatech’s Scientific Advisory Board will be specifically charged to
review each new and existing product to ensure ingredients and
formulations are up to pre-determined standards and are in-line with the
latest, viable research. The board will also be called upon to make
suggestions for new products. Additionally, board members will provide
education and training to Associates on health and wellness topics.
To learn more about Mannatech, its products or business opportunities,
please visit Mannatech.com.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing childhood nutrition where it is needed
most around the world. Mannatech’s proprietary products are available
through independent sales associates around the globe including the
United States, Canada, South Africa, Australia, New Zealand, Austria,
Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom,
Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland,
Czech Republic, the Republic of Korea, Mexico, Namibia, Spain and Hong
Kong. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain associates and
members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150929006585/en/
Source: Mannatech, Incorporated
Mannatech, Incorporated
Kalyn Ballard, 972-471-7245
pr@mannatech.com